| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2B | $5.1B | $5.1B | $4.8B | $4.6B | $3.9B | $4.1B | $4.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.3B | $1.3B | $1.3B | $1.2B | $1.1B | $0.9B | $1.0B | $1.0B |
| Net Income | $1.0B | $1.0B | $1.0B | $0.9B | $0.8B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $19.52 | $19.85 | $19.11 | $17.14 | $15.22 | $3.85 | $3.12 | $3.14 |
| EPS (Diluted) | $19.19 | $19.51 | $18.76 | $16.82 | $14.92 | $3.82 | $3.08 | $3.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $7.9B | $7.5B | $7.0B | $6.8B | $6.6B | $5.7B | $5.4B |
| Current Assets | $4.4B | $4.0B | $3.7B | $3.4B | $3.1B | $3.1B | $2.4B | $2.2B |
| Cash & Equivalents | $1.6B | $1.4B | $1.0B | $0.8B | $0.8B | $0.9B | $0.2B | $0.1B |
| Total Liabilities | $2.5B | $2.5B | $2.5B | $2.5B | $2.6B | $2.7B | $2.3B | $2.3B |
| Current Liabilities | $0.9B | $1.0B | $0.9B | $1.0B | $1.0B | $1.2B | $0.9B | $1.0B |
| Stockholders' Equity | $5.9B | $5.4B | $5.1B | $4.5B | $4.2B | $3.8B | $3.4B | $3.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.2B | $1.2B | $0.7B | $1.0B | $1.0B | $0.7B | $0.8B |
| Investing Cash Flow | $-0.1B | $-0.2B | $-0.3B | $-0.2B | $-0.3B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-0.6B | $-0.6B | $-0.5B | $-0.8B | $-0.1B | $-0.4B | $-0.5B |